CONNECTING TO PERSONS WITH TYPE 1 DIABETES IN CANADA – BETTER CAPACITY FOR CARE / CONNECTER AVEC LES PERSONNES VIVANT AVEC LE DIABÈTE DE TYPE 1 AU CANADA : UNE MEILLEURE CAPACITÉ DE SOINS (DQ-007)

Thursday, October 26, 2023

16:30 – 17:30 EST

Location: Palais, 518ABC

Conférencière(s)

Aude Bandini (she/her/hers)

Associate Professor
Université de Montréal
Université de Montréal
Anne-Sophie Brazeau, PDt, PhD

Assistant professor
McGill University
McGill University
Linxi Mytkolli (she/her/hers)

Patient partner & Lead of patient engagement
Connect1d, Diabetes Action Canada
University of Toronto

Co-modérateur(s)

Peter A. Senior, MD, PhD (he/him/his)

Director
Alberta Diabetes Institute
University of Alberta
Kaberi Dasgupta, MD, MSc (Professor of Medicine and Physician Scientist) (she/her/hers)

Professor of Medicine, Physician, Researcher
McGill University and Centre for Outcomes Research and Evaluation at the Research Institute of the McGill University Health Centre
McGill University

Disclosure(s):

Peter A. Senior, MD, PhD: Bayer: Consultant/Advisory Board (Ongoing); Dexcom: Consultant/Advisory Board (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing); Insulet: Consultant/Advisory Board (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Aude Bandini: No financial relationships to disclose

Anne-Sophie Brazeau, PDt, PhD: Canadian Institute for Health Research: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Dexcom: Speaker/Honoraria (Terminated, January 31, 2023); Diabète Québec: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Fonds de recherche du Québec en Santé: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Juvenile Diabetes Research Foundation: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Mitacs: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Linxi Mytkolli: No financial relationships to disclose

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

Discuss the importance of engaging those with lived experience in supporting clinical care and research;
describe practical considerations for meaningful partnership with individuals living with diabetes to support clinical practice and research; and
present initiatives co-developed with patient-partners to accelerate type 1 diabetes research, support advocacy, and disseminate knowledge in Canada.